Interleukin 5 and B cell differentiation.

[1]  K. Takatsu,et al.  JAK2 and JAK1 Constitutively Associate With an Interleukin-5 (IL-5) Receptor α and βc Subunit, Respectively, and Are Activated Upon IL-5 Stimulation , 1998 .

[2]  M. Tomonaga,et al.  The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human IL-5 receptor. , 1997, International archives of allergy and immunology.

[3]  S. Aizawa,et al.  A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[5]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[6]  C. Bagley,et al.  The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. , 1997, Blood.

[7]  R. Cook,et al.  Mutants of Single Chain Interleukin 5 Show Asymmetric Recruitment of Receptor α and βc Subunits* , 1996, The Journal of Biological Chemistry.

[8]  F. Grosveld,et al.  Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage. , 1996, The EMBO journal.

[9]  A. Miyajima,et al.  Suppression of interleukin‐3‐induced gene expression by a C‐terminal truncated Stat5: role of Stat5 in proliferation. , 1996, The EMBO journal.

[10]  N. Copeland,et al.  Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK‐STAT5 pathway. , 1996, The EMBO journal.

[11]  W. Busse,et al.  IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. , 1996, Journal of immunology.

[12]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[13]  A. Satterthwaite,et al.  Genetic analysis of tyrosine kinase function in B cell development. , 1996, Annual review of immunology.

[14]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[15]  R. Perlmutter,et al.  Impaired expansion of mouse B cell progenitors lacking Btk. , 1995, Immunity.

[16]  F. Alt,et al.  Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.

[17]  R. Egan,et al.  Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.

[18]  S. Stafford,et al.  The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils. , 1995, Journal of immunology.

[19]  A. Satterthwaite,et al.  Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. , 1995, Immunity.

[20]  R. Alam,et al.  The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1- MEK-microtubule-associated protein kinase pathway , 1995, The Journal of experimental medicine.

[21]  S. Carr,et al.  Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins. , 1995, The Journal of biological chemistry.

[22]  T. Taniguchi.  Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.

[23]  P. Coffer,et al.  Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. , 1995, Blood.

[24]  A. Miyajima,et al.  Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs. , 1995, The EMBO journal.

[25]  M. Ichihara,et al.  Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively , 1995, The Journal of experimental medicine.

[26]  K. Takatsu,et al.  A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction , 1994, Molecular and cellular biology.

[27]  N. Sato,et al.  JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region , 1994, Molecular and cellular biology.

[28]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[29]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[30]  G. Yancopoulos,et al.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.

[31]  W. Paul,et al.  Interleukin 5 induces S mu-S gamma 1 DNA rearrangement in B cells activated with dextran-anti-IgD antibodies and interleukin 4: a three component model for Ig class switching , 1993, The Journal of experimental medicine.

[32]  A. Miyajima,et al.  Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5 , 1993 .

[33]  D. S. Webb,et al.  Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. , 1993, Science.

[34]  O. Silvennoinen,et al.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.

[35]  D J Rawlings,et al.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.

[36]  W. Paul,et al.  Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. , 1993, Science.

[37]  A. Tominaga,et al.  Reconstitution of the functional receptors for murine and human interleukin 5 , 1993, The Journal of experimental medicine.

[38]  C. Snapper,et al.  Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells , 1993, The Journal of experimental medicine.

[39]  Ornella Parolini,et al.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.

[40]  D. Bentley,et al.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.

[41]  C. Sanderson.  Interleukin-5, Eosinophils, and Disease , 1992 .

[42]  H. Arakawa,et al.  Biased distribution of recombination sites within S regions upon immunoglobulin class switch recombination induced by transforming growth factor beta and lipopolysaccharide , 1992, The Journal of experimental medicine.

[43]  P. Isakson,et al.  Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE , 1992, The Journal of experimental medicine.

[44]  M. Migita,et al.  Molecular cloning and expression of the human interleukin 5 receptor , 1992, The Journal of experimental medicine.

[45]  A. Kantor.  The development and repertoire of B-1 cells (CD5 B cells). , 1991, Immunology today.

[46]  N. Yamaguchi,et al.  Identification of the second subunit of the murine interleukin‐5 receptor: interleukin‐3 receptor‐like protein, AIC2B is a component of the high affinity interleukin‐5 receptor. , 1991, The EMBO journal.

[47]  J. Tavernier,et al.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific α chain and a β chain shared with the receptor for GM-CSF , 1991, Cell.

[48]  H. Nishimura,et al.  CD5+ B cells in autoimmune disease and lymphoid malignancy. , 1991, Clinical immunology and immunopathology.

[49]  A J Wardlaw,et al.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.

[50]  J. Miyazaki,et al.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production , 1991, The Journal of experimental medicine.

[51]  T. Mosmann,et al.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells , 1990, The Journal of experimental medicine.

[52]  N. Yamaguchi,et al.  Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. , 1990, Journal of immunology.

[53]  N. Yamaguchi,et al.  Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production , 1989, The Journal of experimental medicine.

[54]  R. Coffman,et al.  Brief Definitive Report TRANSFORMING GROWTH FACTOR # SPECIFICALLY ENHANCES IgA PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED , 2022 .

[55]  R. Coffman,et al.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. , 1989, Science.

[56]  N. Yamaguchi,et al.  Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. , 1989, Immunology.

[57]  S. Nishikawa,et al.  Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. , 1989, Growth factors.

[58]  V. Paetkau,et al.  The role of IL-5 in IgA B cell differentiation. , 1988, Journal of immunology.

[59]  N. Yamaguchi,et al.  T Cell‐Replacing Factor (TRF)/Interleukin 5 (IL‐5): Molecular and Functional Properties , 1988, Immunological reviews.

[60]  L. Herzenberg,et al.  The LY‐1B Cell Lineage , 1986 .

[61]  F. Finkelman,et al.  Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. , 1983, Journal of immunology.

[62]  R. Asofsky,et al.  X-linked B lymphocyte defect in CBA/N mice. IV. Cellular and environmental influences on the thymus dependent IgG anti-sheep red blood cell response. , 1979, Journal of immunology.